|
|
|
|
|
|
|
CRISPR Therapeutics AG (CRSP)
|
|
36.04 -1.16 (-3.12%)
|
10-19 16:00
|
|
Open:
|
37.41
|
Pre. Close:
|
37.2
|
|
High:
|
38.35
|
Low:
|
35.69
|
|
Volume:
|
611,867
|
Market Cap:
|
1859M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
38.366 - 38.624
|
38.624 - 38.838
|
|
Low:
|
35.219 - 35.458
|
35.458 - 35.657
|
|
Close:
|
35.688 - 36.078
|
36.078 - 36.401
|
|
|
|
Technical analysis (as of: 2018-10-19 4:33:37 PM)
|
|
Overall:
|
 
|
|
Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.
|
|
Target:
|
Six months: 55.99 One year: 65.56
|
|
Support:
|
Support1: 34.69 Support2: 28.86
|
|
Resistance:
|
Resistance1:
47.94 Resistance2: 56.13
|
|
Pivot:
|
38.02
|
|
Moving Averages:
|
MA(5): 37.70 MA(20): 39.93
MA(100): 52.57 MA(250): 43.71 
|
|
MACD:
|
MACD(12,26):
-3.01 Signal(12,26,9): -3.18
|
|
%K %D:
|
%K(14,3): 25.53 %D(3): 30.01
|
|
RSI:
|
RSI(14): 35.58
|
|
52-Week:
|
High: 73.9
Low: 16.51 Change(%): 85.8
|
|
Average Vol(K):
|
3-Month: 98130
10-Days 128045
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.CRSP has closed above bottom band by 21.1%. Bollinger Bands are 45.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to CRSP's normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.
|
|
|
Headline News
|
|
2018-10-17T11:54:17-04:00
Biotech Analysis Central Pharma News: Roche's Deal, AcelRX Panel Vote, Crispr And Vertex Hold Removal
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
